In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alector closes $29.5mm Series D round

Executive Summary

Just four months after closing a $32mm Series C round, immunotherapeutics start-up Alector LLC (focused on dementia and neurodegeneration) raised $29.5mm through a Series D financing led by Dementia Discovery Fund; other new investors Amgen Ventures and AbbVie also participated, along with return backers Merck Research Lab Ventures, OrbiMed Advisors, Polaris Partners, Google Ventures (now known as GV), Topspin Partners, and Mission Bay Capital.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies